As you can imagine, the pharmaceutical industry is characterized by many regulations and an abundance of meticulous standards that must be met by suppliers and distributors. As an increasing number of products enter the marketplace, the need for tight control measures becomes more prevalent in order to ensure public health and safety. The onus now lies with the suppliers and distributors to meet (perhaps exceed) the standards in place. However, despite these standards certain circumstances have arisen where products have needed to be recalled in the interest of public health. Some of the most prominent drug recalls in terms of scale and magnitude include:
(1) Fenfluramine/Phentermine (Fen-Phen) – developed by Wyeth-Ayerest Labs was recalled in 1997 after 24 years on the market. Fen-Phen was a popular weight loss drug taken by approximately 6.5 million people to help combat obesity. After many users began experiencing heart disease and other related illnesses, the FDA set a recall in motion. The result was roughly $14 billion in damages paid to victims.
(2) Cerivastatin (Baycol) – developed by Bayer and was prescribed to patients as a treatment for high cholesterol and was later linked to a severe muscle disorder. It was recalled in 2001, after roughly 4 years in the market. Damages paid to victims totaled roughly $1.2 billion. Read the rest of this entry »